Author:
Chen Ping,Wang Ying-Peng,Mou Dan-lei,Li Zheng-Yi,Qu Qiu-Min,Wang Hong-Yan,Deng Yuan,Li Xiao-Feng,Wang Ting,Xu Xian-Hao,Zhao Gang
Funder
National Natural Science Foundation of China
47th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, 2nd degree
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference34 articles.
1. Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2(10):797–804
2. Moser B, Bekos C, Zimprich F, Nickl S, Klepetko W, Ankersmit J (2012) The receptor for advanced glycation end products and its ligands in patients with myasthenia gravis. Biochem Biophys Res Commun 420(1):96–101
3. Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100
4. Gronseth GS, Barohn R (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report from the quality standards subcommittee of the American academy of neurology. Neurology 55:7–15
5. Bak V, Spalek P, Petrovajova T, Vichova B, Oravsky M, Luha J, Schnorrer M (2013) Thymic tumours associated with Myasthenia gravis: a long term observation study of operated patients. Bratisl Lek Listy 114(8):464–468
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献